98%
921
2 minutes
20
Ribonucleic acids (RNAs) provide valuable information for biological systems and act as important indicators of disease states. RNAs are diverse in size and structure, and various strategies have been proposed for the detection of nucleic acids; however, developing them into point-of-care (POC) tests has been challenging as most of them consist of complex time-consuming steps. Here, we propose a strategy to assay RNAs using a hairpin-loop (HP) converter and proximity proteolysis reaction (PPR). Interaction between the loop part of HP and its target exposes a single strand of nucleotides, which acts as the template for PPR. A pair of protease and zymogen-conjugated nucleic acids associates with the adjacent regions of the template, resulting in an enhanced proteolysis reaction between protease and zymogen. The activated zymogen then generates a color signal through the hydrolysis of a chromogenic substrate. The combination of HP converter and PPR allowed the same pair of protease- and zymogen-nucleic acids to be used for different RNAs. Guidelines were provided for designing HP converters based on computational analyses and experimental characterizations. This strategy using an HP converter and PPR has been successfully applied to develop simple isothermal methods for the detection of various RNAs, including several microRNAs and KRAS mRNA, in the picomolar range in 1 h. The simplicity of designing HP converters and the beneficial properties of PPR as POC tests would enable the development of novel methods to detect RNAs under low-resource conditions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bios.2021.113769 | DOI Listing |
Biomolecules
July 2025
Univ. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), 71, Avenue des Martyrs, F-38044 Grenoble, France.
AAA+ ATPases are ring-shaped hexameric protein complexes that operate as elaborate macromolecular motors, driving a variety of ATP-dependent cellular processes. AAA+ ATPases undergo large-scale conformational changes that lead to the conversion of chemical energy from ATP into mechanical work to perform a wide range of functions, such as unfolding and translocation of the protein substrate inside a proteolysis chamber of an AAA+-associated protease. Despite extensive biochemical studies on these macromolecular assemblies, the mechanism of substrate unfolding and degradation has long remained elusive.
View Article and Find Full Text PDFUnlabelled: ClpA is an ATP-dependent chaperone essential for protein quality control in . Upon ATP binding, ClpA forms hexameric rings capable of association with the tetradecameric ClpP protease. ClpA couples ATP binding and/or hydrolysis to the unfolding and translocation of protein substrates into the central cavity of ClpP for degradation.
View Article and Find Full Text PDFAngew Chem Int Ed Engl
August 2025
Department of Chemistry, KU Leuven, Celestijnenlaan 200F, Leuven, 3001, Belgium.
Selective proteolysis remains a significant challenge with relevance to industrial and pharmaceutical applications, motivating development of chemical strategies emulating the specificity of natural proteases. Here, we report that the discrete Zr-oxo nanocluster-based solid, [ZrO(OH)(OH)(HCO)(SO)] · 6 HCl · 30 HO (Zr) serves as an efficient, recyclable heterogeneous catalyst for site-selective proteolysis with tunable fragment selectivity. A combination of solution- and solid-state NMR spectroscopy highlighted the importance of the ligand environment of solid Zr for enabling efficient protein-cluster interaction and controlling reactivity.
View Article and Find Full Text PDFAllergy
August 2025
Department of Microbiology, Immunology and Transplantation, Laboratory of Immunobiology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Background: Adaptive IgE-mediated reactions are faster than immune responses that depend on IgM, IgA, and IgG. Normal serum IgE concentrations are highly variable among individuals and extremely low in comparison with those of IgM and IgG. Omalizumab is a clinically approved monoclonal antibody that selectively binds free IgE, preventing allergy-specific IgE from binding to FcεRI expressed on mast cells and basophils, thereby inhibiting degranulation and mediator release.
View Article and Find Full Text PDFACS Appl Mater Interfaces
August 2025
CAS Center for Excellence in Nanoscience, Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing 100190, China.
The majority of lysosome-targeting degradation strategies for membrane proteins rely on recruiting specific lysosome-targeting receptors; however, the low expression levels of these receptors in tumor cells limit their further applications. Herein, we design covalent membrane protein aggregate-targeting chimeras, termed CMPATACs, for tumor-specific membrane protein degradation, which do not rely on specific receptors. We first utilized a covalent reaction to irreversibly bind specific membrane proteins, and this process facilitates the formation of membrane protein aggregates that enter the lysosome for degradation, leading to improved anticancer capacity.
View Article and Find Full Text PDF